Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025)

Fate Therapeutics has reported Long-Term Investments for 7 years, with the latest figure at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Investments fell 94.68% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 94.68% YoY), and the FY2025 full-year result was $1.5 million, down 94.68% from the prior year.
• Long-Term Investments for Q4 2025 stood at $1.5 million, down from $10.3 million in the prior quarter.
• The five-year high for Long-Term Investments was $149.5 million in Q2 2021, with the low at $980000.0 in Q4 2023.
• Historically, Long-Term Investments has averaged $40.5 million across 5 years, with a median of $26.1 million in 2025.
• Annual changes were most pronounced in 2022 — Long-Term Investments slumped 95.09% — and 2024, when it jumped 2722.14%.
• Fate Therapeutics' Long-Term Investments stood at $100.7 million in 2021, then tumbled by 95.09% to $4.9 million in 2022, then slumped by 80.17% to $980000.0 in 2023, then jumped by 2722.14% to $27.7 million in 2024, then tumbled by 94.68% to $1.5 million in 2025.
• The last three Long-Term Investments figures came in at $1.5 million (Q4 2025), $10.3 million (Q3 2025), and $26.1 million (Q2 2025), per Business Quant data.